Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Mao

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|May 2, 2022
Urolithin A as a Potential Drug for the Treatment of Spinal Cord Injuries: A Mechanistic Study Using Network Pharmacology ApproachesChao Mao, HaoPeng Luan, ShuTao Gao, et al.
Nature Reviews. Cancer|October 15, 2025
Exploiting metabolic cell death for cancer therapyChao Mao, Dadi Jiang, Albert C Koong, et al.
Optics Letters|May 1, 2023
High-speed feedback based wavefront shaping for spatiotemporal enhancement of incoherent light through dynamic scattering mediaChao-Mao Hsieh, Mohammad O A Malik, Quan Liu
Journal of Experimental & Clinical Cancer Research : CR|October 28, 2020
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulationTiansheng Li, Chao Mao, Xiang Wang, et al.
Journal of Chemical Neuroanatomy|August 23, 2022
Ulinastatin attenuates spinal cord injury by targeting AMPK/NLRP3 signaling pathwayRui Guo, Shutao Gao, Ying Feng, et al.
Nature|July 5, 2023
Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibitionChao Mao, Xiaoguang Liu, Yuelong Yan, et al.
Foods (Basel, Switzerland)|January 9, 2021
Improving the Solubility and Digestibility of Potato Protein with an Online Ultrasound-Assisted PH Shifting Treatment at Medium TemperatureChao Mao, Juan Wu, Xiangzhi Zhang, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica|March 11, 2015
[Biological characteristics of an Hog1 MAPK homologous gene FoHog1 knock-out mutant of Fusarium oxysporum f. sp. cubense]Chao Mao, Pingya Chen, Qingdong Dai, et al.
Signal Transduction and Targeted Therapy|March 11, 2021
IL4I1-driven AHR signature: a new avenue for cancer therapyZuli Wang, Tiansheng Li, Chao Mao, et al.
Frontiers in Immunology|June 28, 2023
Editorial: Progress of programmed cell death in antitumor immunityFangfang Yan, Chao Mao, Elaine Lai-Han Leung, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Evidence-Based Complementary and Alternative Medicine : Ecam|May 2, 2022
Urolithin A as a Potential Drug for the Treatment of Spinal Cord Injuries: A Mechanistic Study Using Network Pharmacology ApproachesChao Mao, HaoPeng Luan, ShuTao Gao, et al.
Nature Reviews. Cancer|October 15, 2025
Exploiting metabolic cell death for cancer therapyChao Mao, Dadi Jiang, Albert C Koong, et al.
Optics Letters|May 1, 2023
High-speed feedback based wavefront shaping for spatiotemporal enhancement of incoherent light through dynamic scattering mediaChao-Mao Hsieh, Mohammad O A Malik, Quan Liu
Journal of Experimental & Clinical Cancer Research : CR|October 28, 2020
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulationTiansheng Li, Chao Mao, Xiang Wang, et al.
Journal of Chemical Neuroanatomy|August 23, 2022
Ulinastatin attenuates spinal cord injury by targeting AMPK/NLRP3 signaling pathwayRui Guo, Shutao Gao, Ying Feng, et al.
Nature|July 5, 2023
Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibitionChao Mao, Xiaoguang Liu, Yuelong Yan, et al.
Foods (Basel, Switzerland)|January 9, 2021
Improving the Solubility and Digestibility of Potato Protein with an Online Ultrasound-Assisted PH Shifting Treatment at Medium TemperatureChao Mao, Juan Wu, Xiangzhi Zhang, et al.
Wei Sheng Wu Xue Bao = Acta Microbiologica Sinica|March 11, 2015
[Biological characteristics of an Hog1 MAPK homologous gene FoHog1 knock-out mutant of Fusarium oxysporum f. sp. cubense]Chao Mao, Pingya Chen, Qingdong Dai, et al.
Signal Transduction and Targeted Therapy|March 11, 2021
IL4I1-driven AHR signature: a new avenue for cancer therapyZuli Wang, Tiansheng Li, Chao Mao, et al.
Frontiers in Immunology|June 28, 2023
Editorial: Progress of programmed cell death in antitumor immunityFangfang Yan, Chao Mao, Elaine Lai-Han Leung, et al.
Pageof 15